avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Prop1
|
ENSMUSG00000044542.3 | paired like homeodomain factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Prop1 | mm10_v2_chr11_-_50953745_50953768 | -0.09 | 5.9e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 12.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.5 | 9.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
2.1 | 6.3 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
1.3 | 3.8 | GO:0006067 | ethanol metabolic process(GO:0006067) |
1.0 | 3.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 2.8 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.8 | 4.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.8 | 26.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.8 | 3.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.7 | 8.0 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 2.3 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.6 | 2.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.6 | 1.7 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 3.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 1.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.5 | 0.5 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
0.5 | 3.1 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.5 | 1.9 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.5 | 1.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.5 | 1.4 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.4 | 2.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.4 | 2.0 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 3.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 2.6 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.9 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.3 | 0.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.3 | 7.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 3.2 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.3 | 11.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 2.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.3 | 2.4 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.3 | 4.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 2.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 0.8 | GO:0002879 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 1.7 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 1.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 6.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 2.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.8 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 1.2 | GO:0033762 | response to glucagon(GO:0033762) mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 3.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 5.7 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.2 | 1.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.5 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.1 | GO:0098734 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.2 | 8.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.5 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.2 | 0.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:1902019 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 2.1 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 3.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.8 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 1.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.5 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 5.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 1.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 2.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 2.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 1.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 2.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 1.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 1.1 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:0014878 | regulation of muscle atrophy(GO:0014735) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 2.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.2 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.1 | 0.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 2.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.5 | GO:1900042 | common-partner SMAD protein phosphorylation(GO:0007182) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 1.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 1.6 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 1.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 1.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.0 | 2.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 1.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 2.1 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 1.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.6 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 1.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 2.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 1.2 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 2.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.6 | 1.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.4 | 3.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.6 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.9 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 1.2 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 9.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 2.8 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 2.9 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 3.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 4.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 3.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 1.1 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) cuticular plate(GO:0032437) |
0.1 | 2.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.2 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 2.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 9.1 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 4.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 4.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 8.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 3.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 8.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 2.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.7 | 15.9 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.6 | 8.0 | GO:0008142 | oxysterol binding(GO:0008142) |
1.2 | 3.5 | GO:1902271 | D3 vitamins binding(GO:1902271) |
1.2 | 11.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.1 | 3.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.9 | 9.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.9 | 4.3 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.8 | 3.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 3.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.7 | 5.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.7 | 2.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.0 | GO:0031403 | lithium ion binding(GO:0031403) |
0.6 | 3.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.5 | 1.5 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.5 | 12.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.4 | 1.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 3.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 1.9 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.4 | 1.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 13.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 1.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 0.9 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.3 | 1.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 2.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.7 | GO:0008410 | CoA-transferase activity(GO:0008410) palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 4.0 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 4.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 6.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 4.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 1.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.4 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 3.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 7.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.1 | 1.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 2.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 2.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 2.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 3.8 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 2.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 2.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.2 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.1 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.0 | 2.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 2.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.7 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 2.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 1.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 1.9 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 2.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 3.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 4.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 2.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 1.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 1.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 13.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 6.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 3.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 2.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 3.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 9.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 5.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 2.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 4.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 24.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 4.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 2.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 6.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 5.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 3.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 3.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 3.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 2.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 3.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.8 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |